| Dr Pamela Carol Malchoff, OD | |
|
18 W Avon Rd, Avon, CT 06001-3583 | |
| (860) 675-3937 | |
| (860) 673-2555 |
| Full Name | Dr Pamela Carol Malchoff |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 12 Years |
| Location | 18 W Avon Rd, Avon, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306100664 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 002855 (Connecticut) | Primary |
| Provider Name | Moore Eye Care Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1689873820 PECOS PAC ID: 0547152530 Enrollment ID: O20040325001066 |
News Archive
In the June 13 issue of Science Translational Medicine, an international team led by researchers from the University of California, San Diego School of Medicine reports that the new technology of exome sequencing is not only a promising method for identifying disease-causing genes, but may also improve diagnoses and guide individual patient care.
Every day, stem cells in our bone marrow produce billions of new red blood cells. Any disruption in this process can result in serious disease. Researchers from Charité - Universitätsmedizin Berlin and Harvard Medical School have succeeded in furthering our understanding of how blood cells are formed.
According to the Alzheimer's Association, over 5 million Americans are afflicted with Alzheimer's disease. While its cause is controversial, many people believe a correlation exists with toxin accumulation. Until recently, chelation, an invasive, drug-based toxin removal therapy, has been patients' primary option.
Blood clots are increasingly common in cancer patients, but University of Rochester Medical Center researchers have created a novel risk model that can predict, with 98 percent certainty, which patients will not get a blood clot.
› Verified 8 days ago
| Provider Name | Villacis Eyecare Iv, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1962170035 PECOS PAC ID: 3678971025 Enrollment ID: O20211015000029 |
News Archive
In the June 13 issue of Science Translational Medicine, an international team led by researchers from the University of California, San Diego School of Medicine reports that the new technology of exome sequencing is not only a promising method for identifying disease-causing genes, but may also improve diagnoses and guide individual patient care.
Every day, stem cells in our bone marrow produce billions of new red blood cells. Any disruption in this process can result in serious disease. Researchers from Charité - Universitätsmedizin Berlin and Harvard Medical School have succeeded in furthering our understanding of how blood cells are formed.
According to the Alzheimer's Association, over 5 million Americans are afflicted with Alzheimer's disease. While its cause is controversial, many people believe a correlation exists with toxin accumulation. Until recently, chelation, an invasive, drug-based toxin removal therapy, has been patients' primary option.
Blood clots are increasingly common in cancer patients, but University of Rochester Medical Center researchers have created a novel risk model that can predict, with 98 percent certainty, which patients will not get a blood clot.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pamela Carol Malchoff, OD 18 W Avon Rd, Avon, CT 06001-3583 Ph: (860) 675-3937 | Dr Pamela Carol Malchoff, OD 18 W Avon Rd, Avon, CT 06001-3583 Ph: (860) 675-3937 |
News Archive
In the June 13 issue of Science Translational Medicine, an international team led by researchers from the University of California, San Diego School of Medicine reports that the new technology of exome sequencing is not only a promising method for identifying disease-causing genes, but may also improve diagnoses and guide individual patient care.
Every day, stem cells in our bone marrow produce billions of new red blood cells. Any disruption in this process can result in serious disease. Researchers from Charité - Universitätsmedizin Berlin and Harvard Medical School have succeeded in furthering our understanding of how blood cells are formed.
According to the Alzheimer's Association, over 5 million Americans are afflicted with Alzheimer's disease. While its cause is controversial, many people believe a correlation exists with toxin accumulation. Until recently, chelation, an invasive, drug-based toxin removal therapy, has been patients' primary option.
Blood clots are increasingly common in cancer patients, but University of Rochester Medical Center researchers have created a novel risk model that can predict, with 98 percent certainty, which patients will not get a blood clot.
› Verified 8 days ago
Oculus, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 380 W Main St, Lenscrafters, Avon, CT 06001 Phone: 860-409-4565 | |
Dr. Pari Shah, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 49 W Main St, Avon, CT 06001 Phone: 860-676-2376 | |
Dr. Harneet Dhillon Mcdermott, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 43 W Main St, Avon, CT 06001 Phone: 860-676-2376 | |
Dr. Michael James Shiembob, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 315 West Main Street, Avon, CT 06001 Phone: 860-678-3937 Fax: 860-678-7217 | |
Dr. Beth A Salonia, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 380 W Main St, Avon, CT 06001 Phone: 860-409-4565 | |
Dr. Daniel Thomas Fitzpatrick, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 40 Avon Meadow Lane, Avon, CT 06001 Phone: 860-677-6444 Fax: 860-677-4836 |